Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 860 of 1,261

  1. US 8501722

    Methods and compositions for treating bacterial infection

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  2. US 8501776

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  3. MX 2013007491

    GRANULATES COMPRISING ESLICARBAZEPINE ACETATE.

    BIAL PORTELA & CA SA [PT] · Granted Aug 1, 2013 · Expires Jul 27, 2033

    granted

  4. EP 2620148

    Antitumorkombination mit Cabazitaxel und Cisplatin

    AVENTIS PHARMA SA [FR] · Granted Jul 31, 2013 · Expires Jul 26, 2033

    granted

  5. US 8497258

    Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  6. US 8497271

    Modulators of G protein-coupled receptor 88

    LEXICON PHARMACEUTICALS, INC. · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  7. US 8497287

    Aminotetralin compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  8. US 8497290

    Thiocolchicine derivatives, method of making and methods of use thereof

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  9. US 8497274

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  10. US 8497301

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  11. US 8497307

    Aryl guanidine F1F0-ATPase inhibitors and related methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  12. US 8497357

    Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom

    Nektar Therapeutics · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  13. US 8497241

    WNT10-derived peptide and use thereof

    CAREGEN CO., LTD. · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  14. US 8497295

    Spiroindoline modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  15. US 8496938

    Anti-CD100 neutralizing neutralizing antibodies and methods of using the same

    VACCINEX, INC. · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  16. US 8497249

    Fungicidal properties of three saponins from Capsicum frutescens

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  17. US 8497393

    Process to prepare treprostinil, the active ingredient in Remodulin®

    United Therapeutics Corporation · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  18. US 8497279

    Treatment for discoid lupus

    Rigel Pharmaceuticals, Inc. · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  19. US 8497381

    Antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  20. US 8496957

    Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  21. US 8492340

    Methods of treating depression and other related diseases

    Northwestern University · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  22. US 8491886

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  23. US 8492337

    Targeted therapeutic proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  24. US 8492347

    Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus

    The Regents of the University of California · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.